Clinical Trial Results: Pembrolizumab and Carboplatin in Treating Patients With Circulating Tumor Cells Positive Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pembrolizumab with carboplatin in metastatic breast cancer patients positive for circulating tumor cells; results completed and posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Northwestern University | Conditions: Estrogen Receptor Negative, Estrogen Receptor Positive | Phase 2 | Status: COMPLETED | Results posted: 2026-06-17